Gonadorelin Overview, Dosing & Safety | Peptide Database

Gonadorelin (GnRH)

Gonadotropin-Releasing Hormone | GnRH Agonist

Community Research

Join others researching Gonadorelin — share findings, ask questions, and learn from real experiences

Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn regulate testosterone production in men and ovulation in women. It is FDA-approved for diagnostic testing and fertility treatment. The pulsatile nature of GnRH secretion is critical for proper reproductive function.

Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.

Molecular Data

pGlu

Position 1

Histidine

Position 2

Tryptophan

Position 3

Serine

Position 4

Tyrosine

Position 5

Glycine

Position 6

Leucine

Position 7

Arginine

Position 8

Proline

Position 9

Position 10

NH2

Position 11

Research Indications

Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.

Induces ovulation in women with hypothalamic amenorrhea who don't ovulate regularly.

Stimulates testosterone and sperm production by restoring LH/FSH pulsatility.

Treatment of delayed puberty due to hypothalamic-pituitary dysfunction.

Used to assess hypothalamic-pituitary function and diagnose GnRH deficiency.

Evaluates pituitary reserve and responsiveness to GnRH stimulation.

Maintains testicular function and fertility during testosterone replacement therapy.

Helps restore natural testosterone production after anabolic steroid use.

Treatment of undescended testes in pediatric patients.

Dosing Protocols

Can be administered as single injections or via pulsatile infusion pump. Single injections are used for diagnostic testing, while pulsatile administration mimics natural GnRH secretion for therapeutic purposes. Very short half-life (10-40 minutes) requires careful dosing strategy.

Diagnostic testing

100 mcg

Single injection

SubQ or IV

Fertility support

50-100 mcg

2-3x weekly

SubQ

Pulsatile therapy

5-20 mcg per pulse

Every 90-120 min

SubQ pump

TRT adjunct

100-200 mcg

Reconstitution Instructions

Bacteriostatic water (BAC)

Insulin syringes (0.5-1 mL)

Alcohol swabs

Peptide vial

Sterile work surface

1 Clean work area and hands thoroughly

2 Calculate required BAC water volume

3 Draw BAC water into syringe

4 Inject slowly down vial side (not directly onto powder)

5 Gently swirl until dissolved (never shake)

6 Store in refrigerator, use within 14 days

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Injection site reactions

Headache

Flushing

Nausea

Abdominal discomfort

Stop Signs - Discontinue if:

Signs of allergic reaction (rash, difficulty breathing)

Severe headaches

Unusual abdominal pain

Contraindications

Hormone-sensitive tumors

Pregnancy

Hypersensitivity to GnRH or analogs

Conditions worsened by sex hormone release

Quality Checklist

Good Signs

White lyophilized powder

Clear solution after reconstitution

Intact vacuum seal

Warning Signs

Slight clumping that dissolves easily

Bad Signs

Discolored powder

Cloudy or particulate solution

Broken seal

Frequently Asked Questions

Why is pulsatile Gonadorelin dosing critical, and what happens with continuous dosing?

Gonadorelin must be dosed in pulses (every 90-120 minutes) to mimic natural GnRH secretion patterns. Continuous exposure paradoxically causes GnRH receptor desensitization and downregulation, suppressing LH and FSH release—the opposite of desired effects. Proper pulsatile timing is essential for therapeutic success.

Is Gonadorelin better than hCG for maintaining testicular function during TRT?

Both Gonadorelin and hCG maintain testicular function and fertility during TRT, but they work differently. hCG directly mimics LH with a 24-36 hour half-life, while Gonadorelin stimulates natural LH/FSH release but requires pulsatile dosing. hCG is simpler to administer; Gonadorelin offers more physiological restoration of the HPG axis.

How quickly does Gonadorelin raise testosterone after injection?

Gonadorelin has an extremely short 2-4 minute half-life, triggering LH release within minutes. Testosterone elevation from LH stimulation begins within hours, with peak levels at 6-12 hours post-injection. This rapid response makes it suitable for diagnostic testing and pulsatile protocols.

Can Gonadorelin be used long-term for post-cycle therapy, or just short-term?

Gonadorelin is effective for both acute (diagnostic) use and extended post-cycle protocols lasting 2-3 weeks. However, its extreme sensitivity to dosing frequency makes it less practical long-term than hCG or clomiphene. Most PCT protocols use Gonadorelin initially then transition to other agents for maintenance.

References

Pulsatile GnRH administration effectively restores fertility in patients with hypothalamic hypogonadism.

Pulsatile GnRH secretion (every 60-120 min) is essential for proper FSH/LH release and reproductive function.

Effective treatment for ovulation induction in women with hypothalamic amenorrhea.

Related Peptides

Often used as alternative to hCG for testicular stimulation during TRT.

Used alongside TRT to maintain testicular function and fertility.

Kisspeptin stimulates GnRH release; can work together for hormone optimization.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.